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Abstract 
BPH remains one of the most common diseases that the urologist has to manage. The last decade brought numerous new 
techniques, aiming to improve the minimally invasive approach to BPH, but, for the moment, none had changed the place of TURP 
as the gold standard treatment for medium sized prostates. 
Based on a large personal experience, the authors present a study in which TURP is used for prostates over 80ml, the 
cutoff point set by the guidelines of the European Association of Urology. The rationale for this study is that many situations require 
minimally invasive treatment, based on the express request of the patient, other conditions that makes open surgery very difficult or 
impossible, or the need for a quick discharge in an overcrowded service. The aim of the study was to prove that TURP is safe and 
effective even in larger prostates. The technique used is basically the classic one, with minor tactical alterations in some cases. 
Some cases required a two-stage approach, but offered good functional results after the first stage. The results proved that, with a 
good technique, a skilled urologist might achieve the same results by using TURP or open surgery for large sized prostates. 
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Introduction 
Benign prostatic hyperplasia is a progressive 
disease affecting an important number of men. The 
increase in public awareness and the numerous 
campaigns aiming to get men with LUTS to the specialist 
further increased the number of BPH cases, especially in 
those patients with mild and medium symptoms. The 
scientific and technological evolution led to the 
development of many non-surgical treatment alternatives, 
limiting the indications of surgery. Despite all that, there 
still is a great number of patients with large prostates and 
severe symptoms or complications of BPH, requiring 
surgery. 
TURP developed itself to become the gold 
standard of surgical treatment for medium sized 
prostates. The EAU guidelines, based on grade A 
evidence, recommends TURP for prostates between 35 
and 80 ml. Over that limit, open surgery seems to remain 
the only option for treating BPH, according to available 
clinical evidence. 
Still, in many cases, for the experienced 
urologist, TURP may represent a better alternative, first of 
all as a personal option, and second, as an option 
imposed by the need for short hospitalization and lower 
costs [1]. 
No need to remember the option of the patient, 
nowadays better informed and with many options ahead, 
who will ask for the least invasive treatment that will offer 
the best results, with minimal complications rate and that 
will allow him to restart his usual activities as soon as 
possible. 
New technologies, including lasers, plasma 
vaporization, etc, are not suitable options for large 
prostates, and the lack of experience and clinical 
evidence may represent a drawback in recommending 
them to a vast number of patients [2]. 
In our country, the incidence of large sized 
prostates is higher than in other European countries, 
mainly due to the poor primary care offered in rural areas. 
This aspect is improving rapidly, but is still not uncommon 
to see patients with extremely severe LUTS, installed 
years ago, who never required or received any medical 
advice concerning their condition. 
Based on the experience of our department, 
where more than 400 surgeries for BPH are performed 
every year, by several urologists, many of them 
successfully performing TURP even for prostates over 
100ml, we performed a prospective study aiming to 
comparatively evaluate open surgery and TURP for 
prostates over 80ml. Journal of Medicine and Life Vol. 3, No. 4, October‐December 2010 
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Patients and method 
A single center, prospective, randomized study 
was proposed and performed, aiming to comparatively 
evaluate the results of TURP and open surgery, in terms 
of both intraoperative and postoperative features, for 
patients with prostatic volumes over 80 ml. This trial was 
presented to the local ethics committee and approved. 
The patients that were included signed an 
informed consent properly describing the two techniques, 
and also the aims, method and expected benefit of the 
trial. Known hazards and the recommendations in the 
EAU Guidelines were also presented, along with the vast 
experience of our department in performing TURP for 
large prostates. The consent also stated that, in the TURP 
arm, the patient might have to undergo two interventions, 
in four weeks time, if local conditions will require. 
The target population for the study was 
represented by all the male subjects with prostates over 
80ml and indication for surgery that could theoretically 
undergo both open and endoscopic intervention. The 200 
subjects were randomized using sealed envelopes 
previously prepared and containing the name of the 
intervention - open surgery or  TURP – in equal 
proportions. The study started in April 2008 and reached 
its target in November 2009. 
The evaluation protocol included, in all cases, 
general clinical examination with DRE, blood tests, urine 
dipstick, abdominal ultrasonography, uroflowmetry, IPSS 
questionnaire and PSA measurement. In selected cases 
we performed IVP, KUB, cystoscopy and other tests 
relevant for the particular situation. IIEF-5 questionnaire 
was used to assess the sexual function of our patients. A 
three-day bladder diary was recorded before the 
intervention. All the data from the evaluation was 
recorded in the patient’s file. 
The prostatic volume was calculated by 
ultrasonography, using the following formula:  
Volume = height X width X length X 0.52 
Open surgery was performed using the 
suprapubic technique, with hypogastric incision and 
manual enucleation of the prostate. TURP was performed 
using the Storz Electroresection Unit, with the 24Fr 
working element and the classic loop. In some cases, 
several technical artifacts needed to be used, like axial 
movement of the resectoscope, suprapubic cystostomy 
during resection, starting the resection at 6 o’clock or 12 
o’clock, etc. In some cases, according to the size of the 
prostatic lobes, the operative time and the intensity of the 
bleeding, the operator decided to stop the intervention 
after removing the right lobe and to continue the resection 
after four weeks. This attitude was considered normal, 
and not reported as a complication of the intervention. In 
these cases, data was analyzed globally for the two 
interventions, considering that, in the end, the patient was 
treated endoscopically by one doctor. 
The interventions were performed by six 
urologists, three for each group, with relevant expertise 
and personal options for performing either open or 
endoscopic surgery for BPH. The patients were randomly 
assigned to the doctors in the respective groups. 
All the interventions were performed under spinal 
anesthesia. Patients were followed-up for three to six 
months, by evaluating the IPSS, Qmax, residual volume, 
urine infection and PSA.  
The study aimed to evaluate the total operative 
time, the amount of bleeding (evaluated by the need of 
transfusion), the mean time of catheterization, the total 
time of hospitalization, and the overall complication rate. 
The complications were rated minor and major, and 
assessed as intraoperative, postoperative (if they 
occurred during hospitalization) and complications during 
the follow up period. 
The data was statistically analyzed using 
dedicated software, by means of Student’s t test and chi 
square test, in order to evaluate the differences between 
values. The confidence level in this analysis reached 
95%. 
Results 
Data analysis showed that the two arms of the 
study contain population with similar demographic and 
urologic features, and that comparing the obtained data is 
relevant for our objective. Each group consisted of 100 
patients. 
In our series of TURP, the largest prostate 
treated measured 150 ml, with a mean value of 95 ml. In 
the open surgery group, the largest prostate was 
measured at 160 ml, with a mean value of 90 ml. 
In 42 cases, in the TURP arm, the prostate was 
removed in two interventions, and the final result was 
consistent with the general features of the TURP arm. 
The main elements that lead to the decision of performing 
two interventions were poor visibility due to bleeding or 
increased time of resection (over 45 minutes for one 
lobe). No particular complications or features were 
encountered in this subgroup. 
The mean operative time was 50 minutes (40-
75) for TURP and 65 minutes (45-85) for open surgery. In 
the subgroup of patients that underwent two TURPs, the 
time was analyzed for each intervention. We noticed that 
in all such cases, the second TUR took significantly less 
time than the first. Time was measured from the insertion 
of the resectoscope to the insertion of the catheter in the 
first arm, or from the incision to the last stitch for open 
surgery.  
For the TURP arm, we calculated a medium 
value of 1.8ml/min of resected tissue, a value above the 
average known from the literature. 
The mean time of catheterization was 4 days 
after TURP and 9 days in the open prostatectomy arm. In 
eight cases in the TURP arm, the patient developed acute 
urinary retention after the catheter was removed, so a Journal of Medicine and Life Vol. 3, No. 4, October‐December 2010 
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new catheter was placed for 7 days. After that period, 
spontaneous micturition was obtained by 5 patients.  
Post TUR syndrome occurred in 2 patients, but, 
with adequate therapy measures, both patients recovered 
completely. 
In the open prostatectomy arm, one patient died 
during the intervention due to massive myocardial 
infarction that did not respond to therapy. We consider 
this case as a complication of a known condition, and not 
of the particular urological technique. 
Urinary incontinence was diagnosed after the 
removal of the catheter in 38 patients in the TURP arm 
and in 16 cases in the open surgery arm. In all cases, it 
was considered as a predictable outcome of the 
intervention and no therapeutic actions were taken. After 
three months, 5 patients in the TURP arm are still 
incontinent, compared to 3 patients in the open 
prostatectomy arm. 
Overactive bladder syndrome was diagnosed 
during follow up in 7% of the cases treated by TURP and 
in 4.5% of the cases treated by open prostatectomy. In all 
cases, anticholinergic therapy was initiated. We noticed 
that the occurrence of such symptoms made all suffering 
patients unhappy with the result of their surgery. 
De novo erectile dysfunction was diagnosed in 
14.8% of the cases who underwent TURP and in 4% of 
the cases in the open surgery group. The statistical 
analysis could not establish a correlation between the 
prostatic volume and the occurrence of ED. 
Urethral strictures, diagnosed due to the 
reappearance of obstructive symptoms, occurred in 3 
patients in the TURP arm, and all needed surgical 
treatment.  
Osteitis pubis was diagnosed in 6 cases after 
open prostatectomy and is considered a disabling 
condition, although symptomatic relief is usually rapidly 
obtained by using analgesics and anti-inflammatory 
drugs. 
Prostate cancer was diagnosed in 5 cases in the 
TURP arm and in 2 cases in the open prostatectomy arm. 
There is no particular explanation, in our opinion, for this 
difference, other than hazard. 
 Discussions 
In our clinical department are available many 
new modern treatment alternatives for BPH, including 
green laser, plasma vaporization, bipolar TUR, etc. The 
limited experience, higher costs, and the limited 
indications in patients with large prostates make the new 
techniques less useful for these patients, and not an 
option in the long run. 
On the other hand, the vast experience with 
large prostates treated by open or endoscopic surgery 
allows us a more flexible approach in indicating TURP for 
a prostate that, according to the EAU Guidelines, is more 
appropriate for open surgery. In this decision, a great role 
is played by the patient, who, aware of the many new 
developments in medicine, asks for non-scaring surgery 
[3]. 
There is enough data in the literature to support 
the decision of performing TURP for a large prostate, in 
terms of safety and efficacy. Unfortunately, most studies 
compare TURP for small prostates with open 
prostatectomy for large prostates, so the results may be 
interpreted both as a difference between techniques or 
between series of patients [4]. 
The costs of the interventions may be different 
from one country to another, and that is why we did not try 
to compare this aspect with data from other studies. 
An important issue is that contemporary series of 
open prostatectomies are rare, and so are the patients 
with prostates over 80 ml, especially in Western countries. 
Although there is not enough epidemiological data to 
support the affirmation, we may say that the incidence of 
such prostates is significantly higher in Eastern European 
countries, and the experience of large medical centers in 
these countries is quite relevant [5]. 
A multicentric, international study published in 
1989 by Roos, comparing open prostatectomy and TURP, 
it can be concluded that endoscopy is less effective in 
terms of symptomatic relief and might associate a higher 
long-term mortality. Nevertheless, the authors did not 
perform a correlation of the prostatic volume with the 
findings of their study [6].  
A retrospective study on over 5000 patients 
treated for BPH by open surgery concludes that the 
technique is not evolving any more, and that the 
complications, both early and late, are well known, as well 
as their chances of occurrence [7].  We may speculate 
that the situation is similar concerning TURP – the 
technique is old enough to be a gold standard, and it does 
not evolve any more. 
In a study published in 1998, Mearini stresses 
that open surgery still has a strong indication in the 
treatment of BPH, therefore every urologist needs to 
develop its skills in traditional surgery [8]. But, because 
the incidence of large prostates is decreasing, so is the 
experience of the new generation of urologists, more used 
with endoscopy and more prone to using it more and 
more. 
In 2001 Tubaro published his observations on a 
relatively small series of open prostatectomies, for 
prostates averaging 63g at enucleation, concluding that 
open prostatectomy offers probably the maximum 
obtainable relief of obstruction and therefore should be 
considered the reference standard for evaluating all other 
treatments for BPH [9].  
In a study published in 1999 in California, the 
authors observe that TURP has significantly developed in 
the 1990s, offering significantly lower perioperative and 
postoperative complication rates than before, while 
improving efficacy. At the same time, the average hospital Journal of Medicine and Life Vol. 3, No. 4, October‐December 2010 
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stay and catheterization time have constantly decreased 
in time [10]. 
Although the decision between open or 
endoscopic surgery for BPH seems clear based on the 
recommendations from the Guidelines, there are several 
aspects that may change things in daily practice. In the 
first aspect, there are the personal options of the urologist 
and the patient for one or the other technique. Strong 
arguments in favor of TURP are the good results in the 
long run, along with shorter hospital stay and 
catheterization times. 
Conclusions 
Although newer and more promising techniques 
are readily available in the daily practice, TURP and open 
surgery are still the only reliable methods for performing a 
correct and complete prostatectomy in patients with large 
prostates. 
Data in the literature clearly states that, for 
prostates over 80ml, the open technique should be the 
treatment of choice, due to the increased rate of 
complications and better overall outcome. Despite the 
numerous studies supporting the recommendations, there 
is enough data to support TURP for large prostates, 
taking into account some special indications or other 
particular aspects that led to this modified attitude. 
Nevertheless, our study proves that, in 
experienced hands, using the proper technique, TURP 
may lead to similar results, while keeping the complication 
rate low and obtaining shorter hospitalization times and 
lower costs. It is clear for us that TURP for large prostates 
is an intervention not to be performed by the beginner 
endoscopist, or by the faint hearted. However, with 
adequate training and systematic approach, it becomes a 
safe, clean and efficient technique. 
Our study compares TURP with open 
prostatectomy, for large sized prostates. Nevertheless, 
the results sustain the idea that, in experienced hands, 
TURP is equally effective for both mid-sized and large 
prostates. 
The main disadvantages we encountered after 
TURP were a slightly higher rate of urinary incontinence 
and urethral strictures. We consider that these are known 
outcomes after TURP, so that our results can be 
interpreted as normal, and not particular due to a larger 
prostate. All our results indicate that, even for large 
prostates, TURP may lead to the same results it would 
have for a prostate smaller than 80 ml. 
Taking into account all that, we may consider 
that other non-medical aspects may lead to the decision 
of operating endoscopically a large prostate, and this 
includes the necessity for short hospitalization, the 
increased addressability of the service or several 
urologists working there, or the continuously increasing 
patients’ option for minimally invasive surgery. 
It is also obvious for us that, in the end, the final 
option is a matter of personal training and experience – 
there are many urologists who will perform TURP for a 
large prostate, and there are urologists who will feel safer 
performing open surgery for a mid-sized prostate. In this 
aspect, our study proves that the endoscopist who will 
decide to operate a large prostate is not wrong in his 
decision. 
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